Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Lilenbaum

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Cancer|October 12, 2001
Phase II trial of weekly docetaxel in second-line therapy for nonsmall cell lung carcinomaR C Lilenbaum, M A Schwartz, L Seigel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 16, 2004
Phase II randomized trial of vinorelbine and gemcitabine versus carboplatin and paclitaxel in advanced non-small-cell lung cancerR C Lilenbaum, C-S Chen, T Chidiac, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1994
Phase I study of topotecan and cisplatin in patients with advanced solid tumors: a cancer and leukemia group B studyA A Miller, J B Hargis, R C Lilenbaum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
Phase I and pharmacologic study of continuous infusion topotecan in combination with cisplatin in patients with advanced cancer: a Cancer and LeukemiaGroup B studyR C Lilenbaum, A A Miller, G Batist, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1995
Phase I study of paclitaxel and topotecan in patients with advanced tumors: a cancer and leukemia group B studyR C Lilenbaum, M J Ratain, A A Miller, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Cancer|October 12, 2001
Phase II trial of weekly docetaxel in second-line therapy for nonsmall cell lung carcinomaR C Lilenbaum, M A Schwartz, L Seigel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 16, 2004
Phase II randomized trial of vinorelbine and gemcitabine versus carboplatin and paclitaxel in advanced non-small-cell lung cancerR C Lilenbaum, C-S Chen, T Chidiac, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1994
Phase I study of topotecan and cisplatin in patients with advanced solid tumors: a cancer and leukemia group B studyA A Miller, J B Hargis, R C Lilenbaum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
Phase I and pharmacologic study of continuous infusion topotecan in combination with cisplatin in patients with advanced cancer: a Cancer and LeukemiaGroup B studyR C Lilenbaum, A A Miller, G Batist, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1995
Phase I study of paclitaxel and topotecan in patients with advanced tumors: a cancer and leukemia group B studyR C Lilenbaum, M J Ratain, A A Miller, et al.
Pageof 2